
    
      Prior to stem cell infusion, participants will receive a preparative regimen of total
      lymphoid irradiation (TLI), fludarabine, cyclophosphamide, melphalan, and thiotepa to prepare
      their bone marrow. Thereafter, they will receive a hematopoietic cell graft from a
      haploidentical donor and an unrelated umbilical cord blood donor. Post-transplantation
      immunosuppressive treatment will include tacrolimus and mycophenolate mofetil.
    
  